Literature DB >> 10067918

Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection.

K R Wagner1, G Xi, Y Hua, M Zuccarello, G M de Courten-Myers, J P Broderick, T G Brott.   

Abstract

OBJECT: Ultra-early hematoma evacuation (< 4 hours) after intracerebral hemorrhage (ICH) may reduce mass effect and edema development and improve outcome. To test this hypothesis, the authors induced lobar hematomas in pigs.
METHODS: The authors infused 2.5 ml of blood into the frontal cerebral white matter in pigs weighing 8 to 10 kg. In the treatment group, clots were lysed with tissue plasminogen activator ([tPA], 0.3 mg) and aspirated at 3.5 hours after hematoma induction. Brains were frozen in situ at 24 hours post-ICH and hematomal and perihematomal edema volumes were determined on coronal sections by using computer-assisted morphometry. Hematoma evacuation rapidly reduced elevated cerebral tissue pressure from 12.2+/-1.3 to 2.8+/-0.8 mm Hg. At 24 hours, prior clot removal markedly reduced hematoma volumes (0.40+/-0.10 compared with 1.26+/-0.13 cm3, p < 0.005) and perihematomal edema volumes (0.28+/-0.05 compared with 1.46+/-0.24 cm3, p < 0.005), compared with unevacuated control lesions. Furthermore, no Evans blue dye staining of perihematomal edematous white matter was present in brains in which the hematomas had been evacuated, compared with untreated controls.
CONCLUSIONS: Hematomas were quickly and easily aspirated after treatment with tPA, resulting in significant reductions in mass effect. Hematoma aspiration after fibrinolysis with tPA enabled removal of the bulk of the hematoma (> 70%), markedly reduced perihematomal edema, and prevented the development of vasogenic edema. These findings in a large-animal model of ICH provide support for clinical trials that include the use of fibrinolytic agents and ultra-early stereotactically guided clot aspiration for treating ICH.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10067918     DOI: 10.3171/jns.1999.90.3.0491

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  47 in total

1.  A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III).

Authors:  Wendy C Ziai; Nichol McBee; Karen Lane; Kennedy R Lees; Jesse Dawson; Paul Vespa; Richard E Thompson; A David Mendelow; Carlos S Kase; J Ricardo Carhuapoma; Carol B Thompson; Steven W Mayo; Pat Reilly; Scott Janis; Craig S Anderson; Mark R Harrigan; Paul J Camarata; Jean-Louis Caron; Mario Zuccarello; Issam A Awad; Daniel F Hanley
Journal:  Int J Stroke       Date:  2019-04-03       Impact factor: 5.266

2.  Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.

Authors:  Daniel F Hanley; Richard E Thompson; Michael Rosenblum; Gayane Yenokyan; Karen Lane; Nichol McBee; Steven W Mayo; Amanda J Bistran-Hall; Dheeraj Gandhi; W Andrew Mould; Natalie Ullman; Hasan Ali; J Ricardo Carhuapoma; Carlos S Kase; Kennedy R Lees; Jesse Dawson; Alastair Wilson; Joshua F Betz; Elizabeth A Sugar; Yi Hao; Radhika Avadhani; Jean-Louis Caron; Mark R Harrigan; Andrew P Carlson; Diederik Bulters; David LeDoux; Judy Huang; Cully Cobb; Gaurav Gupta; Ryan Kitagawa; Michael R Chicoine; Hiren Patel; Robert Dodd; Paul J Camarata; Stacey Wolfe; Agnieszka Stadnik; P Lynn Money; Patrick Mitchell; Rosario Sarabia; Sagi Harnof; Pal Barzo; Andreas Unterberg; Jeanne S Teitelbaum; Weimin Wang; Craig S Anderson; A David Mendelow; Barbara Gregson; Scott Janis; Paul Vespa; Wendy Ziai; Mario Zuccarello; Issam A Awad
Journal:  Lancet       Date:  2019-02-07       Impact factor: 79.321

3.  Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial.

Authors:  Neal Naff; Michael A Williams; Penelope M Keyl; Stanley Tuhrim; M Ross Bullock; Stephan A Mayer; William Coplin; Raj Narayan; Stephen Haines; Salvador Cruz-Flores; Mario Zuccarello; David Brock; Issam Awad; Wendy C Ziai; Anthony Marmarou; Denise Rhoney; Nichol McBee; Karen Lane; Daniel F Hanley
Journal:  Stroke       Date:  2011-08-25       Impact factor: 7.914

Review 4.  Experimental intracerebral hemorrhage: avoiding pitfalls in translational research.

Authors:  Matthew A Kirkman; Stuart M Allan; Adrian R Parry-Jones
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-24       Impact factor: 6.200

Review 5.  Intracerebral hemorrhage: pathophysiology and therapy.

Authors:  Guohua Xi; Matthew E Fewel; Ya Hua; B Gregory Thompson; Julian T Hoff; Richard F Keep
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

6.  Do current animal models of intracerebral hemorrhage mirror the human pathology?

Authors:  Opeolu Adeoye; Joseph F Clark; Pooja Khatri; Kenneth R Wagner; Mario Zuccarello; Gail J Pyne-Geithman
Journal:  Transl Stroke Res       Date:  2010-08-10       Impact factor: 6.829

7.  Human brain hemorrhage: quantification of perihematoma edema by use of diffusion-weighted MR imaging.

Authors:  J Ricardo Carhuapoma; Peter B Barker; Daniel F Hanley; Paul Wang; Norman J Beauchamp
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

8.  In vivo testing of a non-invasive prototype device for the continuous monitoring of intracerebral hemorrhage.

Authors:  Madhuvanthi A Kandadai; Joseph J Korfhagen; Shauna Beiler; Chris Beiler; Kenneth Wagner; Opeolu M Adeoye; George J Shaw
Journal:  J Neurosci Methods       Date:  2014-07-02       Impact factor: 2.390

9.  Management of acute subdural hematomas in infants: intrathecal infusion streptokinase for clot lysis combined with subdural to subgaleal shunt.

Authors:  Sergey N Larionov; Vladimir A Sorokovikov; Vladimir A Novozilov
Journal:  Childs Nerv Syst       Date:  2007-09-27       Impact factor: 1.475

10.  The Modified Graeb Score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome.

Authors:  Timothy C Morgan; Jesse Dawson; Danielle Spengler; Kennedy R Lees; Chanel Aldrich; Nishant K Mishra; Karen Lane; Terence J Quinn; Marie Diener-West; Christopher J Weir; Peter Higgins; Mark Rafferty; Katie Kinsley; Wendy Ziai; Issam Awad; Matthew R Walters; Daniel Hanley
Journal:  Stroke       Date:  2013-01-31       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.